Published in JAMA on April 28, 1975
Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut (2000) 2.17
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol (2008) 1.56
A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort. Arthritis Rheumatol (2014) 0.91
A clinical approach to the use of methotrexate for sarcoidosis. Thorax (1999) 0.90
Study of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate. Ann Rheum Dis (1997) 0.80
Dermatomyositis: observations on the use of immunosuppressive therapy and review of literature. Cairo--Glasgow study group. Postgrad Med J (1978) 0.75
Is methotrexate carcinogenic? Br Med J (1980) 0.75
Psoriatic arthritis with acral lentiginous melanoma: role for methotrexate? Indian J Dermatol (2013) 0.75
The clinical picture of diabetic control, studied in four settings. Am J Public Health Nations Health (1967) 5.00
A study of diabetic patients at home. Am J Public Health Nations Health (1967) 2.95
Autologous fat transplantation. Long-term follow-up. J Dermatol Surg Oncol (1992) 1.88
Teratogenic evaluation of 2,4,5-T. Science (1970) 1.83
Pasteurella multocida infections following animal injuries, especially cat bites. Arch Dermatol (1972) 1.62
Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. Arch Dermatol (1971) 1.57
Familial cold urticaria. A generalized reaction involving leukocytosis. Arch Intern Med (1969) 1.53
Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994. J Am Acad Dermatol (1996) 1.45
Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma. Blood (1996) 1.44
Erythema gyratum repens in a healthy woman. J Am Acad Dermatol (1992) 1.38
Patient population of a referral medical center. Health Serv Res (1966) 1.38
Estrogen-induced porphyria cutanea tarda. Report of three cases. Arch Dermatol (1970) 1.30
Treatment of multiple facial syringomas with the carbon dioxide (CO2) laser. Dermatol Surg (1999) 1.25
Association between chloroform levels in finished drinking water supplies and various site-specific cancer mortality rates. J Environ Pathol Toxicol (1979) 1.23
The impact of toxicity on carcinogenicity studies: implications for risk assessment. Carcinogenesis (1988) 1.20
Trends in the presentation and treatment of basal cell carcinomas. J Dermatol Surg Oncol (1986) 1.18
Selection of the experimental unit in teratology studies. Teratology (1975) 1.14
Atypical keloids after dermabrasion of patients taking isotretinoin. J Am Acad Dermatol (1986) 1.12
Cutaneous T-cell lymphoma in patients with human immunodeficiency virus infection. Arch Dermatol (1991) 1.11
Alternatives to Rothman's approach for assessing synergism (or antagonism) in cohort studies. Am J Epidemiol (1978) 1.11
Reduced fertility in female mice exposed transplacentally to diethylstilbestrol (DES). Fertil Steril (1982) 1.11
Liposuction for lipomas. J Dermatol Surg Oncol (1985) 1.10
Pseudomonas aeruginosa in dermatology. Arch Dermatol (1968) 1.07
Carbon dioxide (CO2) laser vaporization for the treatment of multiple trichoepithelioma. J Dermatol Surg Oncol (1984) 1.06
Medical uses of intra-arterial injections of reserpine. Treatment of Raynaud syndrome and of some vascular insufficiencies of the lower extremities. Arch Dermatol (1974) 1.06
Removal of tattoos by CO2 laser. J Dermatol Surg Oncol (1980) 1.06
Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst (1990) 1.05
Methotrexate guidelines--revised. J Am Acad Dermatol (1982) 1.04
Use of methotrexate in psoriasis. Arch Dermatol (1972) 1.04
Alternatives to using human experience in assessing health risks. Annu Rev Public Health (1987) 1.03
Current surgical management of skin cancer in dermatology. J Dermatol Surg Oncol (1990) 1.03
Suppressor cell function in psoriasis. Arch Dermatol (1980) 1.02
Annular elastolytic giant cell granuloma. A clinicopathologic study of five cases and a review of similar entities. J Am Acad Dermatol (1979) 1.02
Cold urticaria. Postgrad Med (1971) 1.01
Malignant atrophic papulosis (Degos' disease) involving three generations of a family. J Am Acad Dermatol (1997) 1.01
CO2 laser modification of Mohs' surgery. J Dermatol Surg Oncol (1981) 1.00
Lupus-erythematosus-like tinea of the face (tinea faciale). JAMA (1971) 1.00
Hepatotoxicity of methotrexate in the treatment of psoriasis. Arch Dermatol (1971) 0.99
Interaction in epidemiologic studies. Am J Epidemiol (1978) 0.99
Malignant lymphoma presenting with cutaneous granulomas. J Am Acad Dermatol (1984) 0.98
Intra-arterial administration of reserpine. Its use in patients with Raynaud's disease or Raynaud's phenomenon. Arch Intern Med (1970) 0.98
Geriatric herpes zoster. J Am Geriatr Soc (1971) 0.97
Facial and scalp lipomas: case reports and study of prevalence. J Dermatol Surg Oncol (1985) 0.97
Photochemotherapy for mycosis fungoides. Arch Dermatol (1977) 0.97
Lichen myxedematosus. An unusual case with rapid progression and possible internal involvement. Int J Dermatol (1987) 0.97
Lasers in dermatology--1985. J Dermatol Surg Oncol (1985) 0.96
Essentials of Mohs micrographic surgery. J Dermatol Surg Oncol (1988) 0.96
Surgical management of leg ulcers. Dermatol Clin (1987) 0.95
Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst (1990) 0.95
The impact of litter effects on dose-response modeling in teratology. Biometrics (1986) 0.95
Immunotherapy of malignant melanoma with vaccinia virus. Arch Dermatol (1974) 0.95
Infections caused by achloric algae (protothecosis). Arch Dermatol (1971) 0.93
Tumor cell characterization in mycosis fungoides. Cancer (1976) 0.93
Dermatologic manifestations of gastrointestinal disorders. Gastroenterol Clin North Am (1998) 0.93
Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up. J Am Acad Dermatol (1995) 0.93
Ultraviolet radiation for treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am (1995) 0.92
The double scalpel and double punch excision of skin tumors. J Am Acad Dermatol (1982) 0.91
Mycosis fungoides: time to define the best therapy. J Natl Cancer Inst (1990) 0.91
Evaluation of the effectiveness of griseofulvin, tolnaftate, and placebo in the topical therapy of superficial dermatophytoses. J Invest Dermatol (1975) 0.90
Blastomycosis of bone. South Med J (1972) 0.90
Chronic cutaneous herpes simplex. Arch Dermatol (1971) 0.90
Basal cell carcinoma of the head and neck: identification of the high risk patient. Laryngoscope (1980) 0.89
Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy. J Clin Oncol (1991) 0.89
Hand-foot-and-mouth disease. JAMA (1968) 0.89
Carbon dioxide laser vaporization of lymphangioma circumscriptum. J Am Acad Dermatol (1986) 0.89
Human bite marks. Differential diagnosis. Clin Pediatr (Phila) (1989) 0.89
Pruritus in hepatic cholestasis. Pathogenesis and therapy. Arch Dermatol (1985) 0.88
Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group. Cancer Treat Rep (1979) 0.88
Tattooing--history, technics, complications, removal. Cleve Clin Q (1971) 0.88
Hair casts: classification, staining characteristics, and differential diagnosis. J Am Acad Dermatol (1983) 0.87
Localized scleroderma. Arch Dermatol (1975) 0.87
Treatment of dermatofibrosarcoma protuberans with Mohs micrographic surgery. Ann Surg (1988) 0.87
Methotrexate therapy for psoriasis. Guideline revisions. Arch Dermatol (1973) 0.86
The cutaneous mucinoses. J Am Acad Dermatol (1986) 0.86
Selective immunological evaluation of mycosis fungoides. Arch Dermatol (1978) 0.86
Chloracne and chloracnegens. J Am Acad Dermatol (1985) 0.86
Necrotizing vasculitis (erythema elevatum diutinum). Arch Dermatol (1971) 0.86
Autoerythrocyte sensitization syndrome (psychogenic purpura). J Am Acad Dermatol (1992) 0.86
Plane xanthoma and multiple myeloma with lipoprotein--paraprotein complexing. Arch Dermatol (1978) 0.85
Herpes Zoster in the elderly. Postgrad Med (1971) 0.85
Mycophenolic acid for psoriasis. Arch Dermatol (1977) 0.84
Degos' disease (malignant papulosis). Report of three cases with clues to etiology. JAMA (1968) 0.84
The big three of skin cancer: basal cell carcinoma, squamous cell carcinoma, and malignant melanoma. Postgrad Med (1980) 0.84
Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. J Am Acad Dermatol (1986) 0.84
Photochemotherapy in cutaneous T cell lymphoma and parapsoriasis en plaques. Long-term follow-up in forty-three patients. J Am Acad Dermatol (1985) 0.83
Transepidermal potassium ion, chloride ion, and water flux across delipidized and cellophane tape-stripped skin. Dermatologica (1990) 0.83
Liposuction of lipomas. Dermatol Clin (1990) 0.83
Magnetic resonance imaging of cutaneous melanocytic lesions. J Dermatol Surg Oncol (1989) 0.83
Correction of depressed scars following Mohs' surgery: the role of collagen implantation. J Dermatol Surg Oncol (1982) 0.83
Hand-foot-and-mouth disease--it's more common than you think. Am J Dis Child (1972) 0.82
Methotrexate for psoriasis in weekly oral doses. Arch Dermatol (1969) 0.82
Effects in rats and guinea pigs of short-term exposures to sulfuric acid mist, ozone, and their combination. J Toxicol Environ Health (1977) 0.82
Superpulsed lasers: minimizing thermal damage with short duration, high irradiance pulses. J Dermatol Surg Oncol (1987) 0.82
Histologic, immunofluorescent, and antinuclear antibody findings in PUVA-treated patients. J Am Acad Dermatol (1982) 0.81
Secondary syphilis mimicking mycosis fungoides. J Am Acad Dermatol (1980) 0.81
Pemphigus treatment with azathioprine. Clinical and immunologic correlation. Arch Dermatol (1973) 0.81
Uremic pruritus treated with ultraviolet light. JAMA (1980) 0.81
The use of lincomycin in dermatology. South Med J (1968) 0.81
Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome. Blood (1997) 0.80